X-COR Therapeutics

Name: Upstatement
Price range: $

Creating the first commercially-available extracorporeal CO2 removal device that uses ultra-low-blood flow to treat patients with hypercarbic respiratory failure.

2018 President’s Innovation Challenge Finalist

About X-COR Therapeutics

School

Harvard Medical School, Harvard Business School

Lab

Student i-lab

Connect

Website

Stay In Touch

Get the latest news from the Harvard Innovation Labs and keep us updated on yours.

Get the i-lab newsletter
Follow us on Instagram
Tag us on LinkedIn
Share a venture milestone

Awards & Affiliations

More Student i-lab Ventures

LungSphere

Vital T

Know the Blocks Maven

COP Guide

Stay In Touch